$18.43
+3.6%Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
OMDA • NASDAQ
| Omada Health Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
OPERATING ACTIVITIES | ||||
-12.8M | -47.1M | -67.5M | -72.5M | |
5.5M | 4.8M | 4.4M | 4.3M | |
13M | 9.4M | 8.7M | 6.7M | |
8.8M | 5.3M | 6.1M | 1.7M | |
3.7M | -6.6M | -1.5M | -9.1M | |
18.3M | -34.2M | -49.7M | -69M | |
INVESTING ACTIVITIES | ||||
-1.3M | -596K | -416K | -720K | |
-4.5M | -3.3M | -2.5M | -2M | |
-5.8M | -3.9M | -2.9M | -2.7M | |
FINANCING ACTIVITIES | ||||
169.9M | 3.3M | 1.8M | 1.7M | |
-31M | 0.0 | 963K | -1.3M | |
-5.7M | -4.5M | -2.5M | 1.3M | |
133.2M | -1.2M | 179K | 16.3M | |
CASH FLOW SUMMARY | ||||
145.6M | -39.3M | -52.5M | -55.4M | |
76.4M | 115.6M | 168.1M | 223.5M | |
222M | 76.4M | 115.6M | 168.1M | |
16.9M | -38M | -52.7M | -71.7M |
OMDA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 06, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 08, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 07, 2025 | August 07, 2025 | 2025 |
Continue your OMDA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.